FILSPARI (sparsentan)
ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · IMMUNOGLOBULIN A NEPHROPATHY ·+1
RETROPHIN, INC.
Drug class
Angiotensin Inhibiting Agents
The term "angiotensin inhibiting agents" is a broad umbrella descriptor rather than a single distinct regulatory drug class, primarily encompassing pharmacologic classes that suppress the renin-angiotensin-aldosterone system. Read more about Angiotensin Inhibiting Agents
476 drugs in this class 114 manufacturers
Drugs in Angiotensin Inhibiting Agents
TEKTURNA (aliskiren hemifumarate)
ANGIOTENSIN INHIBITING AGENTS · HYPERTENSION
NODEN-LXO US IN
CANDESARTAN CILEXETIL
ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · HYPERTENSION ·+1
Mylan Pharmaceuticals
OLMESARTAN MEDOXOMIL
ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · HYPERTENSION
Lannett Company
CAPTOPRIL
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · DIABETIC NEPHROPATHY ·+3
Major Pharamceuticals
VALSARTAN
ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · HYPERTENSION ·+2
GSK Consumer Healthcare
BENAZEPRIL HCL
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · HYPERTENSION
BLENHEIM PHARMA
RAMIPRIL
ANGIOTENSIN CONVERTING ENZYME (ACE) INHIBITORS · HYPERTENSION ·+4
BLENHEIM PHARMA
CANDESARTAN CILEXETIL
ANGIOTENSIN II RECEPTOR ANTAGONISTS (ARBS) · HYPERTENSION ·+1
NORTHSTAR RX LL
Filter & compare in the drug finder →
Opens the drug finder with Angiotensin Inhibiting Agents preselected. Add indication or manufacturer filters there.
The term "angiotensin inhibiting agents" is a broad umbrella descriptor rather than a single distinct regulatory drug class, primarily encompassing pharmacologic classes that suppress the renin-angiotensin-aldosterone system.
Most notably, this grouping includes angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), alongside direct renin inhibitors.
These agents work by preventing the formation of angiotensin II or selectively blocking its binding to vascular receptors, which promotes vasodilation, reduces systemic vascular resistance, and decreases aldosterone secretion.
Clinically, these medications serve as foundational therapies across major cardiovascular and renal conditions, including hypertension, heart failure with reduced ejection fraction, post-myocardial infarction ventricular dysfunction, and chronic kidney disease, particularly diabetic nephropathy.
-
fda.gov
The term "angiotensin inhibiting agents" is a broad umbrella descriptor rather than a single distinct regulatory drug class, primarily encompassing pharmacologic classes that suppress the renin-angiotensin-aldosterone system
-
nih.gov
The term "angiotensin inhibiting agents" is a broad umbrella descriptor rather than a single distinct regulatory drug class, primarily encompassing pharmacologic classes that suppress the renin-angiotensin-aldosterone system
-
nih.gov
Most notably, this grouping includes angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), alongside direct renin inhibitors
-
mayoclinic.org
Most notably, this grouping includes angiotensin-converting enzyme (ACE) inhibitors and angiotensin II receptor blockers (ARBs), alongside direct renin inhibitors These agents work by preventing the formation of angiotensin II or selectively blocking its binding to vascular receptors, which promotes vasodilation, reduces systemic vascular resistance, and decreases aldosterone secretion Clinically, these medications serve as foundational therapies across major cardiovascular and renal conditions,...
-
nih.gov
Clinically, these medications serve as foundational therapies across major cardiovascular and renal conditions, including hypertension, heart failure with reduced ejection fraction, post-myocardial infarction ventricular dysfunction, and chronic kidney disease, particularly diabetic nephropathy
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.